Lentini Renee 4
4 · ImmunoGen, Inc. · Filed Dec 27, 2023
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Lentini Renee
V.P.-Fin., Prin. Acctg. Off.
Transactions
- Sale
Common Stock
2023-12-26$29.74/sh−6,548$194,738→ 8,452 total - Exercise/Conversion
Common Stock
2023-12-22+15,000→ 15,000 total - Exercise/Conversion
Restricted Stock Unit
2023-12-22−15,000→ 22,500 totalExercise: $0.00→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]Effected pursuant to a trading plan adopted on June 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.74 to $29.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
- [F3]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F4]37,500 RSUs were granted on December 22, 2022, with 40% of such RSUs vesting on the one-year anniversary of the date of grant and the remaining 60% of such RSUs vesting on the eighteen-month anniversary of the date of grant, subject to continued service through each vesting date.